The main task of a clinical microbiology laboratory is to correctly identify pathogens that cause infectious diseases in a short time and to assist clinicians in the implementation of appropriate treatment protocols by determining antibiotic susceptibility profiles. Blood culture is considered the gold standard for diagnosing BSIs. Rapid and accurate pathogen identification is crucial for effective antimicrobial treatment (
11). The average time for positive signaling of blood culture systems is approximately 24 hours. Gram staining and subculture processes also take at least 24 hours. Therefore, at least 48 hours are required for the identification of pathogens that reproduce in blood culture by traditional methods.
In the last decade, several rapid methods (real-time PCR, multiplex PCR, fluorescent in situ hybridization, and peptide nucleic acid hybridization) have come into use for the rapid identification of pathogens. However, not all pathogens can be detected with these methods, and the equipment and reagents required for the method are quite expensive (
12). Over the last ten years, MALDI-TOF-MS has become a widely used tool for the rapid identification of microorganisms cultured on solid media. The MALDI-TOF-MS has had a revolutionary effect in microbiology laboratories due to its rapid and high-throughput detection of various types of pathogens (
13).
Recently, direct identification protocols from positive BCBs have been developed to reduce the time of diagnosis. Several investigations have examined the use of MALDI-TOF-MS for directly identifying microorganisms in BCBs, employing different protocols (
6-
8). Consequently, it is aimed to better analyze the bacterial proteome by performing bacterial protein extraction through pre-processing with in-house and commercial protocols developed before the BCB is analyzed. In this research, we assessed the effectiveness of MALDI-TOF-MS for processing blood cultures using an in-house direct protocol prior to analysis.
In our study, we used a simple method made with equipment that can be easily found in every laboratory. With the use of such simple diagnostic protocols in clinical microbiology laboratories, rapid results can be produced that can positively affect the prognosis. In this study, we found that Gram-negative bacteria were identified more accurately with MALDI-TOF-MS compared to Gram-positive bacteria (92.0% versus 66.4%). These results are similar to other studies with MALDI-TOF-MS in the literature (
9,
14,
15). For example, the identification rate was 85.0% for Gram-negative aerobes, with Gram-positive aerobes following (78.2%) in Lin et al.'s study (
9). In the study by Jo et al., the overall correct identification rate was 81.8% (208/254), with a success rate of 73.9% for Gram-positive isolates and 92.6% for Gram-negative isolates (
14). Mestas et al. found that organisms were correctly identified to the species level, with a significantly higher identification rate for Gram-negative organisms (90.3%) compared to Gram-positive organisms (78.4%) (
15).
These results are supported by previous studies on direct MALDI-TOF MS from positive blood cultures. Tsuchida et al. achieved 85.5% overall accuracy and 76.1% for Gram-positive organisms with an optimized in-house lysis-filtration method (
16). A large-scale study on 538 samples demonstrated a 93.4% accuracy for Gram-negative and 78.9% for Gram-positive bacteria (
17). These findings corroborate our observations and highlight the potential of direct workflows while also confirming limitations in Gram-positive detection.
The correct identification of Gram-negative bacteria has a significant impact on the choice of antimicrobial agent to be used in treatment because there are many antibiotics that can be used to treat Gram-negative bacteria, and resistance to antimicrobials is higher. The in-house method demonstrated high accuracy for Gram-negative bacteria, consistent with findings from previous studies. The lower identification rate for Gram-positive bacteria may be attributed to the complex cell wall structure, lower bacterial concentration, or interference from blood components.
Optimization strategies, including chemical agents such as saponin and SDS, may enhance identification rates. However, similarly, the correct identification rates of Gram-positive bacteria were lower than those of Gram-negative bacteria in these studies (
10,
18-
23). In our study, 17.2% of the isolates were not identified by the method used. Of these, 54.9% were
Staphylococcus species, consisting of 11
S. aureus, 9
S. epidermidis, 4
S. hominis, 3
S. haemolyticus, and 1
S. warneri. The rate of unidentified isolates has been reported to be between 10.0% and 13.0% in other studies (
8,
14,
24). While discordant results were not detected in the Gram-negative bacteria, they were observed in seven Gram-positive bacteria. The rates of discordant results in other studies ranged from 0% to 4%, and it was found to be 2.4% in our study. Most of these results were Gram-positive bacteria, commonly Staphylococci species, as seen in other studies (
14,
24,
25).
The identification of bacteria causing BSI was accomplished in a short time, like 1 hour, with the method used in our study. The short identification period allows the treatment of patients with BSI to be started in a short time. The advantage of this method is that it provides results 48 hours earlier than the traditional identification method (
26). It is also a simple and cost-effective method. Early detection of pathogens causing BSI can significantly reduce mortality rates, especially in critically ill patients, through early and effective treatment (
27). At the same time, if these methods can be used to detect antimicrobial resistance, more accurate treatment protocols specific to the pathogen can be determined. In this way, misuse and overuse of broad-spectrum antibiotics are prevented (
28).
5.1. Conclusions
In conclusion, the in-house method offers a rapid, cost-effective, and practical alternative for direct microbial identification from blood cultures. While Gram-negative bacteria were accurately identified, further improvements are needed to enhance the accuracy for Gram-positive bacteria. Future research should focus on refining lysis and extraction techniques tailored for Gram-positive organisms and integrating the detection of antimicrobial resistance markers directly from blood culture samples. Such advances could support more targeted therapy, reduce hospital stay durations, and limit the emergence of resistance due to inappropriate antimicrobial use.